← FDA Drug Approvals (Drugs@FDA)

PYRIMETHAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-10-25

Drug application

FDA Application #

ANDA216983

Application type

Abbreviated New Drug Application (Generic)

Brand name

PYRIMETHAMINE

Generic name

PYRIMETHAMINE

Active ingredients

PYRIMETHAMINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2022-10-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown